Taiwan FDA registration a8d6ba95ba52272f15be4a12f96a1fc1

"Bidi" CD19 reagent

TW: "必帝" CD19試劑

Taiwan·Risk Class 2·BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY·Registered Apr 19, 2006 – Apr 19, 2011Cancelled

Registration details

Analysis ID: a8d6ba95ba52272f15be4a12f96a1fc1
Customs Code: DHA00601641104

Company information

Manufacturer: BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY
Manufacturer Country: United States
Authorized Representative: Taiwan Branch of American Business Bidi Co., Ltd

Product details

Intended Use: Detection of CD19 antigen on human B lymphocytes.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.5220 Automatic Differentiation Cell Counter
Import Information: import

Dates and status

Registration Date: Apr 19, 2006
Expiry Date: Apr 19, 2011
Cancellation Date: Oct 26, 2012

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for "Bidi" CD19 reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a8d6ba95ba52272f15be4a12f96a1fc1 and manufactured by BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY. The authorized representative in Taiwan is Taiwan Branch of American Business Bidi Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.